These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
120 related items for PubMed ID: 16009095
21. GAD antibody in multiplex diabetic pedigrees of Chinese. Chen T, Ren Y, Long Y, Zhang X, Yu H, Tian H. Diabetes Care; 2007 Dec; 30(12):3091-2. PubMed ID: 17878243 [No Abstract] [Full Text] [Related]
22. C-peptide used in the estimation of islet beta-cell function in diabetes. Gjessing HJ. Dan Med Bull; 1992 Oct; 39(5):438-52. PubMed ID: 1424818 [No Abstract] [Full Text] [Related]
23. [C-peptide]. Dorner M. Ann Med Interne (Paris); 1984 Oct; 135(6):414-5. PubMed ID: 6508045 [No Abstract] [Full Text] [Related]
24. The clinical characteristics of latent autoimmune diabetes in adults and its relation with chronic complications in metabolically poor controlled Turkish patients with Type 2 diabetes mellitus. Arikan E, Sabuncu T, Ozer EM, Hatemi H. J Diabetes Complications; 2005 Oct; 19(5):254-8. PubMed ID: 16112499 [Abstract] [Full Text] [Related]
25. Elevated circulating adiponectin in type 1 diabetes is associated with long diabetes duration. Lindström T, Frystyk J, Hedman CA, Flyvbjerg A, Arnqvist HJ. Clin Endocrinol (Oxf); 2006 Dec; 65(6):776-82. PubMed ID: 17121530 [Abstract] [Full Text] [Related]
27. Adipocytokines as a novel target for the anti-inflammatory effect of atorvastatin in patients with type 2 diabetes. von Eynatten M, Schneider JG, Hadziselimovic S, Hamann A, Bierhaus A, Nawroth PP, Dugi KA. Diabetes Care; 2005 Mar; 28(3):754-5. PubMed ID: 15735224 [No Abstract] [Full Text] [Related]
28. [C-peptide determination in type 1 diabetes]. Zuppinger K, Buetti L, Gallino L, Aebi C. Ther Umsch; 1983 Oct; 40(10):840-4. PubMed ID: 6359556 [No Abstract] [Full Text] [Related]
30. Autoimmune diabetes in adults: lessons from the UKPDS. Desai M, Clark A. Diabet Med; 2008 Aug; 25 Suppl 2():30-4. PubMed ID: 18717976 [Abstract] [Full Text] [Related]
32. Autoimmunity and clinical course in children with type 1, type 2, and type 1.5 diabetes. Gilliam LK, Brooks-Worrell BM, Palmer JP, Greenbaum CJ, Pihoker C. J Autoimmun; 2005 Nov; 25(3):244-50. PubMed ID: 16243484 [Abstract] [Full Text] [Related]
34. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes. Mojiminiyi OA, Abdella NA, Al Arouj M, Ben Nakhi A. Int J Obes (Lond); 2007 Feb; 31(2):213-20. PubMed ID: 16755284 [Abstract] [Full Text] [Related]
35. Glycemic instability in type 1 diabetic patients: Possible role of ketosis or ketoacidosis at onset of diabetes. Sassa M, Yamada Y, Hosokawa M, Fukuda K, Fujimoto S, Toyoda K, Tsukiyama K, Seino Y, Inagaki N. Diabetes Res Clin Pract; 2008 Aug; 81(2):190-5. PubMed ID: 18514964 [Abstract] [Full Text] [Related]
38. Insulin resistance and inflammation in the early phase of type 2 diabetes: potential for therapeutic intervention. Schernthaner GH, Schernthaner G. Scand J Clin Lab Invest Suppl; 2005 Aug; 240():30-40. PubMed ID: 16112958 [Abstract] [Full Text] [Related]
39. Re: A comparison of classification schemes for ketosis-prone diabetes. Nalini R, Maldonado M, Balasubramanyam A. Nat Clin Pract Endocrinol Metab; 2007 Dec; 3(12):E1. PubMed ID: 18026157 [No Abstract] [Full Text] [Related]